APO RESEARCH · REPORT
Wound Care Biologics
Wound Care Biologics is an evolving segment of the advanced wound care market, which includes enzyme based formulations, Biologic Skin Substitutes, xenografts and cell based biogens to promote wound healing.
Product & engineering
Understand the product.
Wound Care Biologics is an evolving segment of the advanced wound care market, which includes enzyme based formulations, Biologic Skin Substitutes, xenografts and cell based biogens to promote wound healing.
Wound care biologics are being frequently used to treat complex burn injuries in patients with the inadequate skin for grafting. Since then, wound care biologics have been established and used to treat the prevalent problem of most complex chronic wounds such as diabetic foot ulcer and venous leg ulcers.
Selected research
Market Structure
Global Wound Care Biologics Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
Wound Care Biologics is an evolving segment of the advanced wound care market, which includes enzyme based formulations, Biologic Skin Substitutes, xenografts and cell based biogens to promote wound healing.
Wound care biologics are being frequently used to treat complex burn injuries in patients with the inadequate skin for grafting. Since then, wound care biologics have been established and used to treat the prevalent problem of most complex chronic wounds such as diabetic foot ulcer and venous leg ulcers.
Global Wound Care Biologics key players include Smith and Nephew, Organogenesis, MiMedx, Integra, Osiris, etc. Global top five players hold a share about 35%.
Read the full market overview
North America is the largest market, with a share about 60%, followed by Europe and Asia-Pacific, having a total share about 35 percent.
In terms of product, Biologic Skin Substitutes is the largest segment, with a share about 55%. And in terms of application, the largest application is Chronic Wounds, followed by Acute Wounds, Surgical Wounds.
Report Includes
This report provides an overview of the global Wound Care Biologics market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Wound Care Biologics and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Wound Care Biologics revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Wound Care Biologics market size, projected growth trends, production technologies, key applications, and end-use industries.
Wound Care Biologics Segment by Company
Smith and Nephew
Organogenesis
MiMedx
Integra
Osiris
Derma Sciences, Inc
Soluble Systems
Amnio Technology, LLC
Medline
Skye® Biologics
Alphatec Spine,Inc.
Pinnacle Transplant Technologies
Wound Care Biologics Segment by Type
Biologic Skin Substitutes
Enzyme Based Formulations
Growth Factors
Wound Care Biologics Segment by Application
Acute Wounds
Chronic Wounds
Surgical Wounds
Wound Care Biologics Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Wound Care Biologics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Wound Care Biologics and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Wound Care Biologics.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Wound Care Biologics in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Wound Care Biologics industry.
Chapter 3: Detailed analysis of Wound Care Biologics companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Wound Care Biologicsrevenue, gross margin, and recent development, etc.
Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 8: Europe by type, by application and by country, revenue for each segment.
Chapter 9: China by type, and by application, revenue for each segment.
Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.
Chapter 12: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Biologic Skin Substitutes
- Enzyme Based Formulations
- Growth Factors
Applications
- Acute Wounds
- Chronic Wounds
- Surgical Wounds
Companies covered
- Smith and Nephew
- Organogenesis
- MiMedx
- Integra
- Osiris
- Derma Sciences, Inc
- Soluble Systems
- Amnio Technology, LLC
- Medline
- Skye® Biologics
- Alphatec Spine,Inc.
- Pinnacle Transplant Technologies
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Market Analysis by Type
- 1.2.1 Global Wound Care Biologics Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
- 1.2.2 Biologic Skin Substitutes
- 1.2.3 Enzyme Based Formulations
- 1.2.4 Growth Factors
- 1.3 Market Analysis by Application
- 1.3.1 Global Wound Care Biologics Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
- 1.3.2 Acute Wounds
- 1.3.3 Chronic Wounds
- 1.3.4 Surgical Wounds
- 1.4 Global Market Growth Prospects
- 1.5 Global Wound Care Biologics Growth Trends by Region
- 1.5.1 Global Wound Care Biologics Market Size by Region: 2021 VS 2025 VS 2032
- 1.5.2 Wound Care Biologics Market Size by Region (2021-2026)
- 1.5.3 Wound Care Biologics Market Size by Region (2027-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
- 1.8 Years Considered
2 Global Wound Care Biologics Market Dynamics
- 2.1 Wound Care Biologics Industry Trends
- 2.2 Wound Care Biologics Industry Drivers
- 2.3 Wound Care Biologics Industry Opportunities and Challenges
- 2.4 Wound Care Biologics Industry Restraints
3 Competitive Landscape by Company
- 3.1 Global Wound Care Biologics Revenue by Company (2021-2026)
- 3.2 Global Wound Care Biologics Players Revenue Ranking, 2024 VS 2025 VS 2026
- 3.3 Global Wound Care Biologics Key Company Head office and Area Served
- 3.4 Global Wound Care Biologics Company, Product Type & Application
- 3.5 Global Wound Care Biologics Company Establishment Date
- 3.6 Market Competitive Analysis
- 3.6.1 Global Wound Care Biologics Market CR5 and HHI
- 3.6.2 Global Top 5 and 10 Wound Care Biologics Players Market Share by Revenue in 2025
- 3.6.3 2025 Wound Care Biologics Tier 1, Tier 2, and Tier 3
4 Wound Care Biologics Market by Type
- 4.1 Global Wound Care Biologics Market Size by Type (2021 VS 2025 VS 2032)
- 4.2 Global Wound Care Biologics Market Size by Type (2021-2032)
- 4.3 Global Wound Care Biologics Market Size Share by Type (2021-2032)
5 Wound Care Biologics Market by Application
- 5.1 Global Wound Care Biologics Market Size by Application (2021 VS 2025 VS 2032)
- 5.2 Global Wound Care Biologics Market Size by Application (2021-2032)
- 5.3 Global Wound Care Biologics Market Size Share by Application (2021-2032)
6 Company Profiles
- 6.1 Smith and Nephew
- 6.1.1 Smith and Nephew Company Information
- 6.1.2 Smith and Nephew Business Overview
- 6.1.3 Smith and Nephew Wound Care Biologics Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.1.4 Smith and Nephew Wound Care Biologics Product Portfolio
- 6.1.5 Smith and Nephew Recent Developments
- 6.2 Organogenesis
- 6.2.1 Organogenesis Company Information
- 6.2.2 Organogenesis Business Overview
- 6.2.3 Organogenesis Wound Care Biologics Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.2.4 Organogenesis Wound Care Biologics Product Portfolio
- 6.2.5 Organogenesis Recent Developments
- 6.3 MiMedx
- 6.3.1 MiMedx Company Information
- 6.3.2 MiMedx Business Overview
- 6.3.3 MiMedx Wound Care Biologics Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.3.4 MiMedx Wound Care Biologics Product Portfolio
- 6.3.5 MiMedx Recent Developments
- 6.4 Integra
- 6.4.1 Integra Company Information
- 6.4.2 Integra Business Overview
- 6.4.3 Integra Wound Care Biologics Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.4.4 Integra Wound Care Biologics Product Portfolio
- 6.4.5 Integra Recent Developments
- 6.5 Osiris
- 6.5.1 Osiris Company Information
- 6.5.2 Osiris Business Overview
- 6.5.3 Osiris Wound Care Biologics Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.5.4 Osiris Wound Care Biologics Product Portfolio
- 6.5.5 Osiris Recent Developments
- 6.6 Derma Sciences, Inc
- 6.6.1 Derma Sciences, Inc Company Information
- 6.6.2 Derma Sciences, Inc Business Overview
- 6.6.3 Derma Sciences, Inc Wound Care Biologics Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.6.4 Derma Sciences, Inc Wound Care Biologics Product Portfolio
- 6.6.5 Derma Sciences, Inc Recent Developments
- 6.7 Soluble Systems
- 6.7.1 Soluble Systems Company Information
- 6.7.2 Soluble Systems Business Overview
- 6.7.3 Soluble Systems Wound Care Biologics Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.7.4 Soluble Systems Wound Care Biologics Product Portfolio
- 6.7.5 Soluble Systems Recent Developments
- 6.8 Amnio Technology, LLC
- 6.8.1 Amnio Technology, LLC Company Information
- 6.8.2 Amnio Technology, LLC Business Overview
- 6.8.3 Amnio Technology, LLC Wound Care Biologics Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.8.4 Amnio Technology, LLC Wound Care Biologics Product Portfolio
- 6.8.5 Amnio Technology, LLC Recent Developments
- 6.9 Medline
- 6.9.1 Medline Company Information
- 6.9.2 Medline Business Overview
- 6.9.3 Medline Wound Care Biologics Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.9.4 Medline Wound Care Biologics Product Portfolio
- 6.9.5 Medline Recent Developments
- 6.10 Skye® Biologics
- 6.10.1 Skye® Biologics Company Information
- 6.10.2 Skye® Biologics Business Overview
- 6.10.3 Skye® Biologics Wound Care Biologics Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.10.4 Skye® Biologics Wound Care Biologics Product Portfolio
- 6.10.5 Skye® Biologics Recent Developments
- 6.11 Alphatec Spine,Inc.
- 6.11.1 Alphatec Spine,Inc. Company Information
- 6.11.2 Alphatec Spine,Inc. Business Overview
- 6.11.3 Alphatec Spine,Inc. Wound Care Biologics Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.11.4 Alphatec Spine,Inc. Wound Care Biologics Product Portfolio
- 6.11.5 Alphatec Spine,Inc. Recent Developments
- 6.12 Pinnacle Transplant Technologies
- 6.12.1 Pinnacle Transplant Technologies Company Information
- 6.12.2 Pinnacle Transplant Technologies Business Overview
- 6.12.3 Pinnacle Transplant Technologies Wound Care Biologics Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.12.4 Pinnacle Transplant Technologies Wound Care Biologics Product Portfolio
- 6.12.5 Pinnacle Transplant Technologies Recent Developments
7 North America
- 7.1 North America Wound Care Biologics Market Size (2021-2032)
- 7.2 North America Wound Care Biologics Market Size by Type
- 7.2.1 North America Wound Care Biologics Market Size by Type (2021-2026)
- 7.2.2 North America Wound Care Biologics Market Size by Type (2027-2032)
- 7.2.3 North America Wound Care Biologics Market Share by Type (2021-2032)
- 7.3 North America Wound Care Biologics Market Size by Application
- 7.3.1 North America Wound Care Biologics Market Size by Application (2021-2026)
- 7.3.2 North America Wound Care Biologics Market Size by Application (2027-2032)
- 7.3.3 North America Wound Care Biologics Market Share by Application (2021-2032)
- 7.4 North America Wound Care Biologics Market Size by Country
- 7.4.1 North America Wound Care Biologics Market Size by Country (2021 VS 2025 VS 2032)
- 7.4.2 North America Wound Care Biologics Market Size by Country (2021-2026)
- 7.4.3 North America Wound Care Biologics Market Size by Country (2027-2032)
- 7.4.4 North America Wound Care Biologics Market Share by Country (2021-2032)
- 7.4.5 United States
- 7.4.6 Canada
- 7.4.7 Mexico
8 Europe
- 8.1 Europe Wound Care Biologics Market Size (2021-2032)
- 8.2 Europe Wound Care Biologics Market Size by Type
- 8.2.1 Europe Wound Care Biologics Market Size by Type (2021-2026)
- 8.2.2 Europe Wound Care Biologics Market Size by Type (2027-2032)
- 8.2.3 Europe Wound Care Biologics Market Share by Type (2021-2032)
- 8.3 Europe Wound Care Biologics Market Size by Application
- 8.3.1 Europe Wound Care Biologics Market Size by Application (2021-2026)
- 8.3.2 Europe Wound Care Biologics Market Size by Application (2027-2032)
- 8.3.3 Europe Wound Care Biologics Market Share by Application (2021-2032)
- 8.4 Europe Wound Care Biologics Market Size by Country
- 8.4.1 Europe Wound Care Biologics Market Size by Country (2021 VS 2025 VS 2032)
- 8.4.2 Europe Wound Care Biologics Market Size by Country (2021-2026)
- 8.4.3 Europe Wound Care Biologics Market Size by Country (2027-2032)
- 8.4.4 Europe Wound Care Biologics Market Share by Country (2021-2032)
- 8.4.5 Germany
- 8.4.6 France
- 8.4.7 U.K.
- 8.4.8 Italy
- 8.4.9 Russia
- 8.4.10 Nordic Countries
9 China
- 9.1 China Wound Care Biologics Market Size (2021-2032)
- 9.2 China Wound Care Biologics Market Size by Type
- 9.2.1 China Wound Care Biologics Market Size by Type (2021-2026)
- 9.2.2 China Wound Care Biologics Market Size by Type (2027-2032)
- 9.2.3 China Wound Care Biologics Market Share by Type (2021-2032)
- 9.3 China Wound Care Biologics Market Size by Application
- 9.3.1 China Wound Care Biologics Market Size by Application (2021-2026)
- 9.3.2 China Wound Care Biologics Market Size by Application (2027-2032)
- 9.3.3 China Wound Care Biologics Market Share by Application (2021-2032)
10 Asia (Excluding China)
- 10.1 Asia Wound Care Biologics Market Size (2021-2032)
- 10.2 Asia Wound Care Biologics Market Size by Type
- 10.2.1 Asia Wound Care Biologics Market Size by Type (2021-2026)
- 10.2.2 Asia Wound Care Biologics Market Size by Type (2027-2032)
- 10.2.3 Asia Wound Care Biologics Market Share by Type (2021-2032)
- 10.3 Asia Wound Care Biologics Market Size by Application
- 10.3.1 Asia Wound Care Biologics Market Size by Application (2021-2026)
- 10.3.2 Asia Wound Care Biologics Market Size by Application (2027-2032)
- 10.3.3 Asia Wound Care Biologics Market Share by Application (2021-2032)
- 10.4 Asia Wound Care Biologics Market Size by Country
- 10.4.1 Asia Wound Care Biologics Market Size by Country (2021 VS 2025 VS 2032)
- 10.4.2 Asia Wound Care Biologics Market Size by Country (2021-2026)
- 10.4.3 Asia Wound Care Biologics Market Size by Country (2027-2032)
- 10.4.4 Asia Wound Care Biologics Market Share by Country (2021-2032)
- 10.4.5 Japan
- 10.4.6 South Korea
- 10.4.7 Taiwan
- 10.4.8 Southeast Asia
- 10.4.9 India
- 10.4.10 Australia
11 South America, Middle East & Africa
- 11.1 South America, Middle East & Africa Wound Care Biologics Market Size (2021-2032)
- 11.2 South America, Middle East & Africa Wound Care Biologics Market Size by Type
- 11.2.1 South America, Middle East & Africa Wound Care Biologics Market Size by Type (2021-2026)
- 11.2.2 South America, Middle East & Africa Wound Care Biologics Market Size by Type (2027-2032)
- 11.2.3 South America, Middle East & Africa Wound Care Biologics Market Share by Type (2021-2032)
- 11.3 South America, Middle East & Africa Wound Care Biologics Market Size by Application
- 11.3.1 South America, Middle East & Africa Wound Care Biologics Market Size by Application (2021-2026)
- 11.3.2 South America, Middle East & Africa Wound Care Biologics Market Size by Application (2027-2032)
- 11.3.3 South America, Middle East & Africa Wound Care Biologics Market Share by Application (2021-2032)
- 11.4 South America, Middle East & Africa Wound Care Biologics Market Size by Country
- 11.4.1 South America, Middle East & Africa Wound Care Biologics Market Size by Country (2021 VS 2025 VS 2032)
- 11.4.2 South America, Middle East & Africa Wound Care Biologics Market Size by Country (2021-2026)
- 11.4.3 South America, Middle East & Africa Wound Care Biologics Market Size by Country (2027-2032)
- 11.4.4 South America, Middle East & Africa Wound Care Biologics Market Share by Country (2021-2032)
- 11.4.5 Brazil
- 11.4.6 South Africa
- 11.4.7 Saudi Arabia
- 11.4.8 Turkey
- 11.4.9 Argentina
- 11.4.9 UAE
- 11.4.9 Egypt
- 11.4.9 Chile
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
- 13.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst